As of 11:31 AM on the 22nd, Celltrion is trading at 292,500 KRW, up 1.92% from the previous day. This is a decline of 8.16% compared to February 19. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Today, foreigners have net sold 22,668 shares of Celltrion, while institutions have net bought 1,000 shares, according to provisional data. Over the past five days, individual investors have net bought 303,169 shares, whereas foreigners and institutions have net sold 180,231 shares and 125,967 shares, respectively.


On March 17, Celltrion was a market topic with the headline "210 billion KRW scale 'Truxima' supply contract... stock price in decline."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing